latest news.
Cosette Pharmaceuticals Partners With Mark Cuban Cost Plus Drug Company to Make CLOMID® More Affordable
The First Fertility Drug to be Offered by Mark Cuban Cost Plus Drug Company
us.
Together, everyone at Cosette contributes to a culture that fosters innovation, celebrates collaboration and recognizes excellence. We are perpetually pursuing the highest quality standards, the most efficient supply chain and innovating every day in everything we do.
leadership.
Our highly experienced leadership team is busy writing the next, most ambitious chapter of our story. Building on a 100+ year heritage, their shared vision of innovation will leverage our expertise, efficiency, and infrastructure to create remarkable new opportunities.
products.
While staying true to our proud therapeutic history of dermatology products, suppositories, and oral liquids, we’re busy expanding our offerings – through strategic partnerships and internal R&D. Our focus on innovation and supply reliability is the foundation of our rapidly diversifying portfolio.
we care.
Cosette is committed to understanding patients’ unique health journeys so we can anticipate their needs and help achieve their goals.
newsroom.
Avista Capital Partners and Hamilton Lane Announce Partnership in Cosette Pharmaceuticals
Avista Capital Partners (“Avista”), a leading New York-based private equity firm focused…
Cosette Pharmaceuticals Acquires Ambien® and Ambien CR® (Zolpidem Tartrate) Tabs from Sanofi US in the US Market
Cosette Pharmaceuticals, Inc. (“Cosette”), a US-based specialty pharmaceutical company, has…
Cosette Pharmaceuticals Announces the Approval and Launch of First Generic Version of RECTIV® (nitroglycerin) ointment, 0.4%, with 180 days Competitive Generic Therapy (CGT) exclusivity
Cosette Pharmaceuticals, Inc. ("Cosette") announced that the U.S. Food and Drug Administration…
